Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy.

MLA

Hendrickson, Sher L., et al. “Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 51, no. 2, June 2009, pp. 111–16. EBSCOhost, https://doi.org/10.1097/QAI.0b013e3181a324d6.

APA

Hendrickson, S. L., Kingsley, L. A., Ruiz-Pesini, E., Poole, J. C., Jacobson, L. P., Palella, F. J., Bream, J. H., Wallace, D. C., & O’Brien, S. J. (2009). Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 51(2), 111–116. https://doi.org/10.1097/QAI.0b013e3181a324d6

Chicago

Hendrickson, Sher L., Lawrence A. Kingsley, Eduardo Ruiz-Pesini, Jason C. Poole, Lisa P. Jacobson, Frank J. Palella, Jay H. Bream, Douglas C. Wallace, and Stephen J. O’Brien. 2009. “Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 51 (2): 111–16. doi:10.1097/QAI.0b013e3181a324d6.